We serve Chemical Name:(E)-Ethyl 3-(4-bromophenyl)acrylate CAS:24393-53-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(E)-Ethyl 3-(4-bromophenyl)acrylate
CAS.NO:24393-53-1
Synonyms:(E)-3-(4-bromophenyl)acrylic acid ethyl ester;Ethyl 3-(4-bromophenyl)acrylate;MFCD00012226;Ethyl (2E)-3-(4-bromophenyl)acrylate;Ethyl trans-4-bromocinnamate;4-Bromocinnamic acid ethyl ester;ETHYL 4-BROMOCINNAMATE;ethyl trans-4-bromo-cinnamate;2-Propenoic acid, 3-(4-bromophenyl)-, ethyl ester;Ethyl (2E)-3-(4-bromophenyl)-2-propenoate;trans-4-Bromocinnamic acid ethyl ester;Ethyl P-broMocinnaMate;Ethyl trans-4-bromociamate;2-Propenoic acid, 3-(4-bromophenyl)-, ethyl ester, (2E)-
Molecular Formula:C11H11BrO2
Molecular Weight:255.108
HS Code:2916399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:308.6±0.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.579
PSA:26.30000
Exact Mass:253.994232
LogP:3.60
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like (E)-3-(4-bromophenyl)acrylic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Propenoic acid, 3-(4-bromophenyl)-, ethyl ester, (2E)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl (2E)-3-(4-bromophenyl)-2-propenoate Use and application,MFCD00012226 technical grade,usp/ep/jp grade.
Related News: Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. (E)-Ethyl 3-(4-bromophenyl)acrylate manufacturer Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. (E)-Ethyl 3-(4-bromophenyl)acrylate supplier From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry. (E)-Ethyl 3-(4-bromophenyl)acrylate vendor Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity. (E)-Ethyl 3-(4-bromophenyl)acrylate factory When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau.
